S. Wilkinson

First name
Last name
Wilkinson, S., Douglas, I. J., Williamson, E., Stirnadel-Farrant, H. A., Fogarty, D., Pokrajac, A., et al. (2018). Factors associated with choice of intensification treatment for type 2 diabetes after metformin monotherapy: a cohort study in UK primary care. Clin Epidemiol. http://doi.org/10.2147/clep.s176142
Wilkinson, S., Douglas, I., Stirnadel-Farrant, H., Fogarty, D., Pokrajac, A., Smeeth, L., & Tomlinson, L. (2018). Changing use of antidiabetic drugs in the UK: trends in prescribing 2000-2017. BMJ Open. http://doi.org/10.1136/bmjopen-2018-022768
Wilkinson, S., Williamson, E., Pokrajac, A., Fogarty, D., Stirnadel-Farrant, H., Smeeth, L., et al. (2020). Comparative effects of sulfonylureas, DPP4is and SGLT2 inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK primary care. Diabetes Obes Metab. http://doi.org/10.1111/dom.13970
Bidulka, P., O\textquoterightNeill, S., Basu, A., Wilkinson, S., Silverwood, R. J., Charlton, P., et al. (2021). Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT study. BMJ Open. http://doi.org/10.1136/bmjopen-2020-046912